Academic Journal
Q2Therapeutic Advances in Ophthalmology
About Therapeutic Advances in Ophthalmology
Therapeutic Advances in Ophthalmology is a scholarly journal published by SAGE Publications Ltd. SCImago 2025 lists it in Q2, with an SJR of 0.795 and H-index of 26.
Coverage: 2018-2026. Research categories: Ophthalmology (Q2).
Open-access policies and author information
Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2024-04-04. This snapshot does not establish today’s listing status or fee quotation.
Publisher policy links recorded by DOAJ
- Aims and scope ↗
- Editorial board ↗
- Instructions for authors ↗
- Peer-review policy ↗
- Publication fees ↗
- Licence terms ↗
Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.
Source-backed journal facts
Topics in published research
Retinal Diseases and Treatments; Glaucoma and retinal disorders; Retinal and Macular Surgery; Corneal surgery and disorders; Ophthalmology and Visual Impairment Studies; Ocular Diseases and Behçet’s Syndrome.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Fluocinolone Acetonide Implant as a Baseline Therapy for Diabetic Macular Edema: Results from the Randomized Phase 4 NEW DAY Study
Michael A. Singer, Charles C. Wykoff, Christopher D. Riemann, Victor H. Gonzalez et al.
2026-09 · DOI: 10.1177/25158414261477639Impact of preoperative deviation control on one-year motor results after intermittent exotropia surgery
Alaa Alghurab, Mohammad Reza Akbari, Shehzad A. Naroo, Foroozan Narooie-Noori et al.
2026-09 · DOI: 10.1177/25158414261489431Reproxalap 0.25% in dry eye disease: A meta-analysis of randomized controlled trials
Muhammad Imaz Bhatti, Mohsin Rashid, Ishmal Fatima Shahid, Saleha Azeem et al.
2026-09 · DOI: 10.1177/25158414261491554Quality of life and its determinants among glaucoma patients attending Berhan Aini Ophthalmic National Referral Hospital: A cross-sectional study
Nuru Abdu, Saleh Idrisnur, Hanae Said, Lude Kifle et al.
2026-09 · DOI: 10.1177/25158414261489414Dry eye disease in thyroid eye disease: A narrative review of pathogenic mechanisms and therapeutic implications
Seyed Mohsen Rafizadeh, Enes Eroglu, Ali A. Haydar, Haniyeh Zeidabadinejad et al.
2026-09 · DOI: 10.1177/25158414261491563Early functional recovery in retinal artery occlusion: a cohort study of factor Xa inhibitor use
Wan-Yu Liu, Yih-Shiou Hwang, Hung-Chi Chen, Wei-Chi Wu et al.
2026-09 · DOI: 10.1177/25158414261466833Evaluation of the usability, efficacy and safety of a novel ophthalmic eye drop dispenser designed to deliver preservative-free artificial tears for the treatment of dry eye disease
Gamze Ozkan, Jesus Pujol-Marti, Stefan Hellbardt, Matthias Birkhoff et al.
2026-09 · DOI: 10.1177/25158414261489406Autologous platelet-rich plasma eyedrops for severe dry eye disease unresponsive to autologous serum: A prospective single-arm interventional study
Thapakorn Sirirattanasoporn, Parichart Taweekitikul, Susama Choksuwattanaskul, Thanachaporn Kittipibul et al.
2026-09 · DOI: 10.1177/25158414261487082Hypoosmolar riboflavin for corneal swelling in thin keratoconic corneas prior to crosslinking: An exploratory study
Clark Y. Chang, Subba R. Gollamudi, Daniel G. Fuller, Chawan Rasheed et al.
2026-09 · DOI: 10.1177/25158414261491466What thriving PhD students do differently lessons, habits, and reflections from the PhD journey
Ana Catalina Rodriguez-Martinez, Mariya Moosajee
2026-09 · DOI: 10.1177/25158414261494176Suprachoroidal hemorrhage and detachment in the non-laser photocoagulation posterior pole after intravitreal Anti-VEGF injection: A case report
Yikeng Huang, Jisen Tang, Chunyao Xie, Xionggao Huang et al.
2026-09 · DOI: 10.1177/25158414261491534Chimeric antigen receptor (CAR) therapies in retinoblastoma: A comprehensive review
Amirmohammad Amoozadehsamakoosh, Hassan Asadigandomani, Mohammadrahim Yavarinejad, Alma Naseri et al.
2026-09 · DOI: 10.1177/25158414261491556An unusual case of iris and lens colobomas: A case report
Cong Ren, Zhang-Chen-Xi Gu, Jun-Guo Guo, Jing Pang et al.
2026-08 · DOI: 10.1177/25158414261487062Wharton’s jelly–derived mesenchymal stem cells in keratoconus
Masoud Khorrami-Nejad, Rawshan Qasim Jumah, Hossein Aghamollaei, Foroozan Narooie-Noori et al.
2026-08 · DOI: 10.1177/25158414261475131Evaluation of the retinal and choroidal microvasculature in retinitis pigmentosa using OCT-angiography: a meta-analysis
Evita Evangelia Christou, Amandeep S. Josan, Robert E. MacLaren
2026-08 · DOI: 10.1177/25158414261471361State-of-the-art advances in tissue-engineered corneal substitutes: a systematic review (2020–2025)
Mario Bonmatí-Echevarría, Carmen González-Gallardo, Miguel Alaminos
2026-08 · DOI: 10.1177/25158414261464536When trifocal IOLs disappoint: diagnostic and management pathway
Masoud Khorrami-Nejad, Ahmed Mohammed Noori, Khosrow Jadidi, Foroozan Narooie-Noori et al.
2026-08 · DOI: 10.1177/25158414261471349Podcast reassurance to equity of implementation: Expanding the therapeutic potential of charles bonnet syndrome education
Rajeev Kumar Jha, Ranjay Kumar Choudhary, Mulavagili Vijayasimha
2026-08 · DOI: 10.1177/25158414261475127Plain language summary of publication of the 96-week results from the PHOTON study: intravitreal aflibercept 8 mg for diabetic macular edema
Diana V. Do, Charles C. Wykoff, Sobha Sivaprasad, David M. Brown et al.
2026-07 · DOI: 10.1177/25158414261459529The efficacy of faricimab in patients with diabetic macular edema and serous neuroretina detachment
Giovanni William Oliverio, Irene Ingrande, Pasquale Aragona, Alessandro Meduri et al.
2026-07 · DOI: 10.1177/25158414261465595Reviews
Community Reviews
Version History
October 2, 2026 at 8:58 pm
October 2, 2026